<DOC>
	<DOCNO>NCT00425126</DOCNO>
	<brief_summary>Delayed graft function ( DGF ) major complication follow decease donor renal transplantation . The surgical procedure harvest kidney cadaveric donor implant kidney recipient inevitably cause amount injury . While always clinically significant , anywhere 10-50 % transplant patient may develop DGF . Ongoing research animal model demonstrate benefit administration erythropoietin . The investigator propose study effect Procrit ( Epoetin Alfa ) delay graft function subject undergo kidney transplantation .</brief_summary>
	<brief_title>Effect Procrit ( Epoetin Alfa ) Preventing Delayed Graft Function After Deceased Donor Renal Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Delayed Graft Function</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Patients present kidney transplantation Age &gt; 18 Deceased donor kidney transplant History thrombosis hypercoagulable state Receiving Coumadin Heparin Hemoglobin &gt; =14 g/dl Uncontrolled hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Delayed Graft Function</keyword>
	<keyword>Kidney Transplantation</keyword>
</DOC>